Philippines: COVID-19 vaccine brand preference 2021

According to a May 2021 survey in the Philippines, Sinovac Biotech was the most preferred coronavirus (COVID-19) brand by Filipino respondents. The brand, which was developed by a Chinese biopharmaceutical company, was chosen by 39 percent of Filipinos. In comparison, 32 percent of the respondents stated that they prefer the Pfizer-BioNTech vaccine brand. At the time of the survey, 71 percent of the COVID-19 vaccines that arrived in the country were China's Sinovac followed by the United Kingdom's AstraZeneca.

Preferred coronavirus (COVID-19) vaccine brand in the Philippines as of May 2021

Characteristic	Share of respondents
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

May 2021

More information

Region

Philippines

Survey time period

April 28 to May 2, 2021

Number of respondents

1,200 respondents

Age group

18 years and older

Method of interview

Face-to-face interview

Supplementary notes

The question was phrased by the source as (translated from Tagalog): "If you could choose the brand of the vaccine approved by the Food and Drug Administration of the Philippines, which of the following would you choose?"

Multiple responses were allowed.

The survey was conducted nationwide with 300 respondents each in Balance Luzon, Metro Manila, the Visayas, and Mindanao.

Citation formats